Spravato

Spravato for treatment-resistant depression

Revolutionizing Treatment to Change Lives

Oak Hills Behavioral Health Solutions understands the challenges of treating TRD. That’s why we’re excited to offer SPRAVATO® (ketamine) CIII, a novel nasal spray used with an oral antidepressant in adults with this difficult-to-treat disorder. This innovative treatment offers hope and potential relief.

Anger and Mood Disorders

Pain management

EMDR Therapy

What is SPRAVATO®?

FDA-Approved for Use in Adults as a Single Form of Esketamine, SPRAVATO® is intended only for treating the following indications and cannot be used in combination to infuse study doses.

Treatment-resistant depression (TRD): For people who have deepening mental illness due to traditional antidepressants.

Severe Suicidal Thoughts & Behavior: Try antidepressants in people who have not responded to other MDD treatments.

As the first-of-its-kind, SPRAVATO® is a medicine that uniquely interacts with the NMDA receptor in the mind, offering a fresh approach to treating conditions when other well-being treatments have failed.

. Before Treatment

A dedicated team will be there to help you decide if SPRAVATO® is right for you. We conduct a thorough analysis, provide the necessary patient intake forms, and work closely with your Primary Care Physician or Pain Management Specialist, ensuring you receive the best possible care.

You must return to a treatment center for SPRAVATO® therapy – you will not be able to self-administer SPRAVATO® at home.

To learn more about our treatment center and how we can work together to provide you with SPRAVATO®, please contact Oak Hills Behavioral Health Solutions at 660-372-1313

For more information about SPRAVATO® or visit http://www.spravato.com

SPRAVATO® is a registered trademark of Johnson & Johnson and its affiliated companies.
© Janssen Pharmaceuticals, Inc. All rights reserved.

Convenient and Accessible Mental Health Services

Located in Moberly, Missouri, our clinic is open six days a week and offers extended hours to accommodate your busy schedule.

We accept various insurance plans and offer a military discount to ensure that quality mental health care is accessible to all who need it.

Question from our clients

01 Who is Spravato treatment for?
Spravato is specifically designed for adults with major depressive disorder (MDD) who have not responded to at least two other antidepressant treatments. It may also be prescribed for individuals experiencing depression with suicidal thoughts or behavior.
Spravato targets the NMDA receptors in the brain, which are involved in mood regulation. Unlike traditional antidepressants that can take weeks or months to show effects, Spravato often provides relief in a shorter time frame, helping reduce symptoms of depression more rapidly.
Spravato treatment involves an initial intensive phase, where you will receive two doses per week for the first four weeks. Afterward, the frequency typically decreases based on your progress. Treatment plans vary for each patient, and our team will work with you to adjust the schedule as needed.
Common side effects of Spravato include dizziness, nausea, increased blood pressure, and dissociation (a feeling of being disconnected from reality). These effects are usually mild and subside after the treatment session. 
Many insurance plans cover Spravato treatment, but coverage may vary depending on your specific plan and provider.

Your Health, Our Priority

Start Your Wellness Journey Today

Let us help you find your solutions!